skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: On December 22, 2017 the 3 stocks concerned concluded the day at $8.28, $767.34, and $68.92. I assume all should be kept for the future. Only GUD is presently is at problematic value. In agreement ?
Read Answer Asked by Serge on December 26, 2017
Q: COV--Spiked after great Q on Dec 18,but today pared gain.Confused.It is a point to add to my 1% holding(p/p $4.55) GUD is having a nice run from recent bottom.On Dec 18 announced that 60P has submitted a new drug to US FDA for approval.Is this material.Any idea when Goodman will strike a big deal?.Is this a goodtime to average down on my $10.16 p/p. Thanks for u usual great services & views. Merry X'mas & All the Best for the N.Y.Continue to provide great picks
Read Answer Asked by Peter on December 21, 2017
Q: With a $150,000 balanced portfolio and about 25 positions, what would be the suggested starting weightings be for each of the KXS, GUD, SHOP and TOY positions?
Read Answer Asked by Tom on December 18, 2017
Q: Good morning. I currently have about 7% in healthcare consisting of GUD (4%) and CELG (3%). I'm considering selling CELG and buying CSH.UN. Do you see this as a good trade? Or alternatively, I could go overweight healthcare and hold all 3...thoughts?
Thanks.
Read Answer Asked by Ian on December 18, 2017
Q: Hello 5i team,
Could you remind me of your rationale for having GUD and KXS in both Balanced and Growth portfolios; whereas Element and Open Text were in the Balanced portfolio, why have you shifted ECN and OTEX to the Growth portfolio?
Looking forward to watch Peter on BNN on Friday.
Thanks,
Antoine
Read Answer Asked by Antoine on December 15, 2017
Q: Knight, Celestica and Lundin Mining are all trading at close to 1:1 price to book (per the Globe). Is that meaningful at all for any of these companies? Is it a "value" indicator that suggests better days may be ahead? Your thoughts, please. With thanks.
Read Answer Asked by Chris on December 12, 2017
Q: I have been watching CZO CLR GUD NLN PLI and GPS for some time and I am considering buying into some of these Companies at these current low prices. I have 2 questions. a) Are the fundamentals sound?? and b) How would you rank them for mid term growth. Thanks for your considered opinion
Read Answer Asked by Bob on December 08, 2017
Q: Cipher is improving and the stock is trending up. With that being said, Knight looks better for the long term if they ever deploy their cash hoard. I currently have a half position in Cipher where a tax loss can be harvested. Take the tax loss and top up my position in Knight while it's down?
Thanks!
Read Answer Asked by WAYNE on December 08, 2017
Q: Hi there, I noticed a recent answer where you recommended COV and GUD for a growth and balanced healthcare name. I know it may be best to split a position in two and own both names, but if you had to buy just one which would it be - for short term (1-2 years) or long term (5-10 years)? Thanks!
Read Answer Asked by Michael on December 07, 2017
Q: Hello Peter and Ryan,
Cannimed has provided the following press release
http://www.businesswire.com/news/home/20171130006170/en/Actions-Words-Aurora-CEO%E2%80%99s-Actions-Reveal-Aurora
which basically illustrates insider selling by Aurora executives on November 28, 2017 while Aurora is in the midst of a takeover of Cannimed.
How is this recent information on insider selling obtained? I am thinking of adding to Savaria Corp giving it total of 5 percent weight and Knight to 7 percent given its recent weakness. Any comments please. Thanks again
Read Answer Asked by umedali on December 01, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!